Tetrahydrocurcumin-induced apoptosis of hepatocellular carcinoma cells involves the TP53 signaling pathway, as determined by network pharmacology

Figure 7 Cell cloning experiment to detect the proliferation capacity of HepG2 and Huh7 cells treated with different concentrations of tetrahydrocurcumin. A: Tetrahydrocurcumin (THC) had a greater effect on the proliferation of hepatocellular carcinoma cells as the treatment concentration increased (25, 50, or 100 μmol/L for 2 weeks); B: Graph of the cell cloning ability of HepG2 and Huh7 cells treated with THC (25, 50, or 100 μmol/L) for 2 weeks. All data are presented as the mean ± SD, n = 3. Compared to the control group, ^aP < 0.05; ^bP < 0.01; THC: Tetrahydrocurcumin.